Co-Diagnostics and CoMira Unveil Automated Manufacturing Line in Utah

June 19, 2026
Co-Diagnostics hosted a delegation from its Saudi joint venture CoMira Diagnostics in Salt Lake City for the unveiling of a future automated PCR test kit manufacturing line, part of a planned technology transfer to Saudi Arabia.

Co-Diagnostics hosted a delegation from CoMira Diagnostics, its joint venture in the Kingdom of Saudi Arabia, for the unveiling of a future automated manufacturing line at its Salt Lake City headquarters, announced in a press release. The event took place on June 17, 2026, and was attended by Utah state officials, trade representatives, and community leaders.

The visit marked the next phase of Co-Diagnostics' partnership with CoMira, which involves transferring molecular diagnostics technology and manufacturing capabilities to Saudi Arabia. The future automated PCR test kit manufacturing line is expected to support rapid scaling of diagnostic production and distribution across Saudi Arabia and 18 other countries in the Middle East and North Africa.

The Co-Dx PCR platform integrates artificial intelligence and cloud-connected outbreak surveillance features to enable real time monitoring of infectious disease trends. These capabilities are planned to be part of the CoMira partnership, aligning with the goal of establishing automated diagnostic infrastructure in international markets.

According to CoMira CEO Ihssan Rjoob, the visit provided insight into the advanced manufacturing systems that will form the foundation of CoMira’s operations in Saudi Arabia. Co-Diagnostics’ platform is designed to support scalable and efficient test production for regional healthcare needs.

We hope you enjoyed this article.

Consider subscribing to one of our newsletters like Enterprise AI Brief, Life AI Weekly or Daily AI Brief.

Also, consider following us on social media:

Enterprise AI Healthcare & Life Sciences AI AI Brief AI Brief (X)

More from: Enterprise

06/19
Dream Raises $260 Million to Expand Sovereign AI Infrastructure for Governments
06/19
Hirevue Introduces AI Interviewer for Voice-Based Candidate Assessment
06/19
Payscore Integrates Income Verification into DoorLoop Tenant Screening
06/19
Threekit Introduces AI Sales Agent for Manufacturing Sellers
06/19
FusionAIrre Names Delta Dental of New Jersey and Connecticut as Flagship Ape-X Assurance Customer

More from: Life Sciences

06/19
Boltz Partners with Takeda to Deploy Biomolecular AI Models in Research
06/19
XEOS Publishes BrIMA Study Showing Improved Breast Surgery Outcomes with Specimen PET-CT
06/19
Arbital Health Launches ATLAS for CMS LEAD Model Financial Planning
06/19
Channel Robotics Raises $4.6 Million to Advance Handheld Endoscopic Robot
06/19
Workera Reports Fourfold Increase in Learning Speed for Medical Device Manufacturer

Subscribe to Industrial AI Weekly

The latest advancements in smart manufacturing, predictive maintenance, AI-driven quality control, supply chain & more.

AI Token Webinar

Whitepaper

Stanford HAI’s 2025 AI Index Reveals Record Growth in AI Capabilities, Investment, and Regulation

The 2025 AI Index by Stanford HAI provides a comprehensive overview of the global state of artificial intelligence, highlighting significant advancements in AI capabilities, investment, and regulation. The report details improvements in AI performance, increased adoption in various sectors, and the growing global optimism towards AI, despite ongoing challenges in reasoning and trust. It serves as a critical resource for policymakers, researchers, and industry leaders to understand AI's rapid evolution and its implications.

Read more

You May Also Like